The results indicate that the heterozygous genotype for the XRCC1 rs1799782 polymorphism in female patients is related to a higher susceptibility to breast cancer than in males [OR 3.627; 95% CI 1.577–8.341]. Here, XRCC1 is linked to breast carcinoma.